Literature DB >> 16412053

Virological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus-infected patients with and without mixed cryoglobulinaemia.

D Sansonno1, G Lauletta, M Montrone, F A Tucci, L Nisi, F Dammacco.   

Abstract

In clinical and pathological terms hepatitis C virus (HCV)-infected patients can be subdivided into two main groups with and without mixed cryoglobulinaemia (MC). Involvement of blood mononuclear cells by HCV has potentially important implications. To this end, HCV-RNA levels in peripheral blood lymphocytes (PBL) preparations of 20 chronically HCV-infected patients with MC were measured and compared with those found in a group of 20 patients without MC matched for age, serum HCV-RNA, infectious genotype, source and presumable duration of infection. Phenotypic abnormalities of PBL subsets in each group of patients were determined by cell surface marker expression and compared. Results showed a significant enrichment of HCV-RNA in PBL of MC patients compared with a non-MC group (P = 0.01). Different distribution of HCV-RNA was accompanied by evidence of an increased frequency of circulating B cells. These data indicate that MC patients are characterized distinctly by a higher quota of cell-associated viral load.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412053      PMCID: PMC1809584          DOI: 10.1111/j.1365-2249.2005.02987.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients.

Authors:  V Racanelli; D Sansonno; C Piccoli; F P D'Amore; F A Tucci; F Dammacco
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

2.  Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells.

Authors:  A Wack; E Soldaini; C Tseng; S Nuti; G Klimpel; S Abrignani
Journal:  Eur J Immunol       Date:  2001-01       Impact factor: 5.532

3.  Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.

Authors:  V Agnello; G Abel; M Elfahal; G B Knight; Q X Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection.

Authors:  S E Bassett; B Guerra; K Brasky; E Miskovsky; M Houghton; G R Klimpel; R E Lanford
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

5.  The origin of hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus.

Authors:  Tomasz Laskus; Marek Radkowski; Jeffrey Wilkinson; Hugo Vargas; Jorge Rakela
Journal:  J Infect Dis       Date:  2002-01-31       Impact factor: 5.226

Review 6.  Interaction between the hepatitis C virus and the immune system.

Authors:  B Rehermann
Journal:  Semin Liver Dis       Date:  2000       Impact factor: 6.115

Review 7.  The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy.

Authors:  F Dammacco; D Sansonno; C Piccoli; V Racanelli; F P D'Amore; G Lauletta
Journal:  Semin Liver Dis       Date:  2000       Impact factor: 6.115

8.  The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines.

Authors:  S Hamaia; C Li; J P Allain
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

9.  Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection.

Authors:  Eli Zuckerman; Aharon Kessel; Gleb Slobodin; Edmond Sabo; Daniel Yeshurun; Elias Toubi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions.

Authors:  Chien-Te K Tseng; Gary R Klimpel
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

View more
  8 in total

1.  Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinaemia.

Authors:  D Sansonno; F A Tucci; G Lauletta; V De Re; M Montrone; L Troiani; L Sansonno; F Dammacco
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 2.  Hepatitis C virus-induced cryoglobulinemia.

Authors:  Edgar D Charles; Lynn B Dustin
Journal:  Kidney Int       Date:  2009-07-15       Impact factor: 10.612

3.  Hepatitis C virus cryoglobulinemia and non-hodgkin lymphoma.

Authors:  Zohreh Jadali
Journal:  Hepat Mon       Date:  2012-02-29       Impact factor: 0.660

4.  Abnormal CD4 + T helper (Th) 1 cells and activated memory B cells are associated with type III asymptomatic mixed cryoglobulinemia in HCV infection.

Authors:  Fanyun Kong; Wei Zhang; Bo Feng; Henghui Zhang; Huiying Rao; Jianghua Wang; Xu Cong; Lai Wei
Journal:  Virol J       Date:  2015-07-01       Impact factor: 4.099

5.  HCV replication in gastrointestinal mucosa: Potential extra-hepatic viral reservoir and possible role in HCV infection recurrence after liver transplantation.

Authors:  Giovanna Russelli; Paola Pizzillo; Gioacchin Iannolo; Floriana Barbera; Fabio Tuzzolino; Rosa Liotta; Mario Traina; Giovanni Vizzini; Bruno Gridelli; Ester Badami; Pier Giulio Conaldi
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

Review 6.  Hepatitis C virus infection and mixed cryoglobulinemia.

Authors:  Gianfranco Lauletta; Sabino Russi; Vincenza Conteduca; Loredana Sansonno
Journal:  Clin Dev Immunol       Date:  2012-07-10

Review 7.  Infection and vasculitis.

Authors:  Cristina C Belizna; Mohamed A Hamidou; Hervé Levesque; Loic Guillevin; Yehuda Shoenfeld
Journal:  Rheumatology (Oxford)       Date:  2009-03-03       Impact factor: 7.580

Review 8.  Virus-induced vasculitis.

Authors:  Hisham Sharlala; Ade Adebajo
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.